GWHP Stock Overview
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Global WholeHealth Partners Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0006 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | -99.00% |
1 Year Change | -99.83% |
3 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
GWHP | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 2.2% | 0.4% |
1Y | -99.8% | 13.3% | 28.8% |
Return vs Industry: GWHP underperformed the US Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: GWHP underperformed the US Market which returned 28.8% over the past year.
Price Volatility
GWHP volatility | |
---|---|
GWHP Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GWHP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine GWHP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | F. Alvarez | https://gwhpcorp.com |
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians’ offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases.
Global WholeHealth Partners Corporation Fundamentals Summary
GWHP fundamental statistics | |
---|---|
Market cap | US$143.00 |
Earnings (TTM) | -US$5.15m |
Revenue (TTM) | US$7.38k |
0.0x
P/S Ratio0.0x
P/E RatioIs GWHP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GWHP income statement (TTM) | |
---|---|
Revenue | US$7.38k |
Cost of Revenue | US$119.68k |
Gross Profit | -US$112.31k |
Other Expenses | US$5.04m |
Earnings | -US$5.15m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GWHP perform over the long term?
See historical performance and comparison